Sleep and respiratory devices maker ResMed (NYSE:RMD) is planning a large-scale research, development and innovation project at its Ireland facility, expecting to add 50 new jobs over the next 3 years.
The company is working on non-contact sensors to help chronic disease patients manage their condition at home, according to Ireland government reports.
ResMed plans to take the project through its entire cycle in Ireland, from product standardization, to software algorithm development and through clinical trials and commercialization.
That places the project "among the most comprehensive medical device development projects ever undertaken by a multinational company in Ireland," according to IDA Ireland, a government institution supporting ResMed’s efforts.
The Irish government touted the project as further evidence that the country is friendly to medical device makers.
"I am delighted that ResMed has joined Ireland’s strong, growing cluster of leading global and indigenous medical device companies," IDA Ireland chief executive Barry O’Leary said in prepared remarks. "This expansion by ResMed Inc is a further endorsement of Ireland’s long established reputation in supporting research, development and innovation."
Intuitive Surgical enjoyed a nearly two-decade monopoly in the robot-assisted surgery space. At DeviceTalks West, we'll delve into that history as longtime CEO Gary Guthart tells us how he got his start in medtech, how Intuitive came to enjoy such a commanding lead and what the future holds for medical robotics.
Use code GUTHART to save an additional 10%.